Literature DB >> 28717437

Fahr disease: Idiopathic basal ganglia calcification.

Gholam Ali Shahidi1, Mahdi Safdarian1.   

Abstract

Entities:  

Keywords:  Fahr Disease; Idiopathic Basal Ganglia Calcification; Tomography; X-Ray Computed

Year:  2017        PMID: 28717437      PMCID: PMC5506759     

Source DB:  PubMed          Journal:  Iran J Neurol        ISSN: 2008-384X


× No keyword cloud information.
A 23-year-old man presented with progressive bulbar and oromandibular dystonia, in addition to distal limbs involvement. In neurological exam, the patient had diverse manifestations, most commonly movement disorder, cognitive impairment, ataxia and speech disorder. Other minor neurologic manifestations included pyramidal signs, psychiatric features, and gait disorders. He had no positive family history, and his parents were not relative. Calcifications in the brain computed tomography scan (CT scan) are seen primarily in the basal ganglia and in other areas such as the cerebral cortex (Figure 1).
Figure 1

Brain computed tomography scan (CT scan) of the patient with Fahr disease (FD) showing bilateral symmetrical calcifications in the basal ganglia and the cerebral cortex (Arrows)

Fahr disease (FD) is a rare genetically dominant, neurodegenerative disorder characterized by idiopathic bilateral deposits of calcium in the striopallidodentate area.[1] Symptoms may include deterioration of motor function, dementia, seizures, headache, dysarthria, spasticity, eye impairments, and athetosis.[2] After ruling out the medical calcium metabolism abnormalities, FD is diagnosed by the presence of extensive bilateral symmetric intracranial calcifications and developmental defects. Brain computed tomography scan (CT scan) of the patient with Fahr disease (FD) showing bilateral symmetrical calcifications in the basal ganglia and the cerebral cortex (Arrows) The major differential diagnosis includes hypoparathyroidism. Bilateral symmetric calcification involving striatum, pallidum, dentate nucleus, thalamus, and white matter is reported from asymptomatic individuals to a variety of neurological conditions. The key point is that there is no known calcium metabolism abnormality in autosomal dominant or sporadic bilateral striopallidodentate calcinosis. Movement disorders, especially Parkinsonism is the most common presentation followed by cognitive impairment and ataxia.[3] Magnetic resonance imaging (MRI) is sensitive in detecting brain abnormalities; however, it is difficult to identify calcifications by routine MRI because calcifications. Therefore, brain CT scan is considered to be critical for detecting and localizing the extent of intracranial calcifications.[4]
  4 in total

Review 1.  What is and what is not 'Fahr's disease'.

Authors:  Bala V Manyam
Journal:  Parkinsonism Relat Disord       Date:  2005-03       Impact factor: 4.891

2.  Fahr disease: use of susceptibility-weighted imaging for diagnostic dilemma with magnetic resonance imaging.

Authors:  Neslin Sahin; Aynur Solak; Berhan Genc; Ugur Kulu
Journal:  Quant Imaging Med Surg       Date:  2015-08

3.  Identification of calcification with MRI using susceptibility-weighted imaging: a case study.

Authors:  Zhen Wu; Sandeep Mittal; Karl Kish; Yingjian Yu; J Hu; E Mark Haacke
Journal:  J Magn Reson Imaging       Date:  2009-01       Impact factor: 4.813

Review 4.  Fahr's syndrome: literature review of current evidence.

Authors:  Shafaq Saleem; Hafiz Muhammad Aslam; Maheen Anwar; Shahzad Anwar; Maria Saleem; Anum Saleem; Muhammad Asim Khan Rehmani
Journal:  Orphanet J Rare Dis       Date:  2013-10-08       Impact factor: 4.123

  4 in total
  1 in total

1.  The Impact of COVID-19 Infection on a Neurologically Compromised Male With Fahr's Disease Presenting With Acute Delirium and Aspiration Pneumonia: A Case Report.

Authors:  Rubal Bhangal; Jasmine K Sandhu; Zaryab Umar; Deesha Shah; Nso Nso
Journal:  Cureus       Date:  2022-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.